Biocartis, Invetech Ink Deal Covering Biomarker Analysis Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Invetech will support the development and manufacture of Biocartis' multiplex platform for biomarker analysis under an agreement announced today.

Invetech will support the development of Biocartis' Evaluation instrument for analyzing protein and nucleic acid-based biomarkers to support clinical research and pharmaceutical applications, the partners said. Evaluation "provides an integrated reaction and detection environment," while enabling the simultaneous investigation of multiple analytes per sample, the companies added.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.